Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications
Authors:
- 19 April 2007
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 17 (4) , 371-384
Abstract
Extensive research into the functions of glutamate and glutamate receptors in the CNS has shown an essential role of metabotropic glutamate (mGlu) receptors not only in normal brain functions but also in neurological and psychiatric disorders. The precise functions of these receptors remain undefined and progress toward understanding their functions had been hampered by the lack of selective ligands with appropriate pharmacokinetic properties. The Group I mGlu receptors, comprising mGlu1 and mGlu5 receptors, are well positioned to regulate and fine-tune neuronal excitability and synaptic transmission through its modulation of various signal transduction pathways and interactions with other transmitter systems. Therefore, the mGlu5 receptor may be an important therapeutic target for the treatment of disorders of the CNS. The discovery of MPEP, a non-competitive mGluR5 antagonist, provided a potent, selective, systemically active tool compound for proof-of-concept studies in animal models of various disease...Keywords
This publication has 68 references indexed in Scilit:
- MOLECULAR MECHANISM OF 7TM RECEPTOR ACTIVATION—A GLOBAL TOGGLE SWITCH MODELAnnual Review of Pharmacology and Toxicology, 2006
- Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potentialPharmacology & Therapeutics, 2004
- Metabotropic glutamate receptors: potential therapeutic applications of recently disclosed new chemical entitiesExpert Opinion on Therapeutic Patents, 2004
- Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonistsBiochemical Society Transactions, 2004
- Allosteric modulators of G-protein-coupled receptorsCurrent Opinion in Pharmacology, 2003
- A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5Molecular Pharmacology, 2003
- Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB‐1893 and MPEPBritish Journal of Pharmacology, 2003
- 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic ActivityJournal of Medicinal Chemistry, 2002
- G Protein-Coupled Receptor Allosterism and ComplexingPharmacological Reviews, 2002
- A model for the functioning of family 3 GPCRsTrends in Pharmacological Sciences, 2002